[{"data": {"name": "Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Kevin R Flaherty", "@type": "Person"}, {"name": "Kevin K Brown", "@type": "Person"}, {"name": "Athol U Wells", "@type": "Person"}, {"name": "Emmanuelle Clerisme-Beaty", "@type": "Person"}, {"name": "Harold R Collard", "@type": "Person"}, {"name": "Vincent Cottin", "@type": "Person"}, {"name": "Anand Devaraj", "@type": "Person"}, {"name": "Yoshikazu Inoue", "@type": "Person"}, {"name": "Florence Le Maulf", "@type": "Person"}, {"name": "Luca Richeldi", "@type": "Person"}, {"name": "Hendrik Schmidt", "@type": "Person"}, {"name": "Simon Walsh", "@type": "Person"}, {"name": "William Mezzanotte", "@type": "Person"}, {"name": "Rozsa Schlenker-Herceg", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc5604725?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "BMJ", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1136/bmjresp-2017-000212", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CC4xb7dMFPyJy-CTPZ9XeKn6sBZ-CDHvpLACobVL2-CRKNDs7oqgiUF", "propertyID": "ISCC"}], "datePublished": "2017-09-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]